IRIS
MERCURIO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.514
EU - Europa 1.026
AS - Asia 764
AF - Africa 57
SA - Sud America 15
OC - Oceania 1
Totale 3.377
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.490
IT - Italia 684
SG - Singapore 342
HK - Hong Kong 205
CN - Cina 119
NL - Olanda 72
DE - Germania 60
VN - Vietnam 39
CI - Costa d'Avorio 37
IE - Irlanda 28
FR - Francia 27
FI - Finlandia 22
CA - Canada 20
GB - Regno Unito 19
PT - Portogallo 19
JP - Giappone 18
IN - India 17
RU - Federazione Russa 17
ES - Italia 16
BE - Belgio 9
EG - Egitto 9
LT - Lituania 8
TR - Turchia 7
BG - Bulgaria 6
CO - Colombia 6
AT - Austria 5
PL - Polonia 5
SE - Svezia 5
AR - Argentina 4
GE - Georgia 4
HR - Croazia 4
MA - Marocco 4
MX - Messico 4
PH - Filippine 3
PK - Pakistan 3
RS - Serbia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
CH - Svizzera 2
CL - Cile 2
GR - Grecia 2
LV - Lettonia 2
MK - Macedonia 2
NO - Norvegia 2
PE - Perù 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
IL - Israele 1
IR - Iran 1
SI - Slovenia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 3.377
Salva come PNG Salva come JPEG
Città #
Chandler 305
Singapore 279
Hong Kong 204
Santa Clara 113
Ashburn 110
Naples 76
Millbury 71
Lawrence 67
Des Moines 51
Amsterdam 46
Boston 44
Napoli 40
Dong Ket 38
Rome 35
Milan 33
Nanjing 25
Wilmington 23
Palermo 20
Beijing 18
Seattle 18
Fairfield 14
Bologna 13
Princeton 13
Shenyang 13
Council Bluffs 12
Catania 11
Bari 10
Caserta 10
Montijo 10
Pune 10
Turin 10
Woodbridge 10
Helsinki 9
Chengdu 8
Houston 8
Manfredonia 8
Marcianise 8
Ottawa 8
Toronto 8
Changsha 7
Dublin 7
Hebei 7
Munich 7
Battipaglia 6
Bogotá 6
Brescia 6
Dallas 6
Foggia 6
London 6
Menlo Park 6
Nanchang 6
Sofia 6
Cambridge 5
Eindhoven 5
Florence 5
Frankfurt am Main 5
Madrid 5
Redwood City 5
Ariano Irpino 4
Cologne 4
Düsseldorf 4
Grottolella 4
Hengshui 4
Kronberg 4
Lappeenranta 4
Leawood 4
Locorotondo 4
Moscow 4
Oeiras 4
Piemonte 4
Pisa 4
Rho 4
St Petersburg 4
Tbilisi 4
Zagreb 4
Ankara 3
Ann Arbor 3
Chiyoda-ku 3
Guangzhou 3
Jiaxing 3
Lisbon 3
Maasmechelen 3
Marigliano 3
Monmouth Junction 3
Norwalk 3
Paris 3
Perugia 3
Pescara 3
Pisogne 3
Rogliano 3
Vilnius 3
Alenquer 2
Alexandria 2
Ancona 2
Andria 2
Arzano 2
Augusta 2
Badajoz 2
Bergamo 2
Boardman 2
Totale 2.055
Salva come PNG Salva come JPEG
Nome #
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice 565
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 93
Antineoplastic drug-induced cardiotoxicity: A redox perspective 72
Cardiac sympathetic dysfunction in pulmonary arterial hypertension: Lesson from left-sided heart failure 70
New drugs, therapeutic strategies, and future direction for the treatment of Pulmonary Arterial Hypertension 62
Severe Aortic Valve Regurgitation in Relapsing Polychondritis 61
Meccanismi molecolari della cardiotossicità indotta da antracicline e radioterapia 61
Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients 59
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue 58
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 56
Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis 54
Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients 54
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 54
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial 52
What is the cardiac impact of chemotherapy and subsequent radiotherapy in lymphoma patients 52
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 51
The use of chest ultrasonography in suspected cases of COVID-19 in the emergency department 50
Adapted recreational football Small Sided Games improves cardiac capacity, body composition and muscular fitness in patients with type 2 diabetes: results from a pilot study 49
Time-weighted lactate as a predictor of adverse outcome in acute heart failure 46
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs 44
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 44
Novel Therapeutic Approaches and Targets for the Treatment of Cardiovascular and Immunological Diseases 42
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 41
Oxidative stress in anticancer therapies-related cardiac dysfunction 41
Cardiovascular events and treatment of children with high risk medulloblastoma 40
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 39
New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management 39
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension. 38
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC) 38
Commentary on “Functional Improvement After Outpatient Cardiac Rehabilitation in Acute Coronary Syndrome Patients is not Related to Improvement in Left Ventricular Ejection Fraction” 38
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure 37
Long-term follow-up in high risk hypertensive patients with carotid dolicoarteriopathies 37
Beta-blockers in pulmonary arterial hypertension: Time for a second thought? 37
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment 36
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: A multicenter, double blind, randomized, placebo controlled trial 36
Endocrine alterations are the main determinants of cardiac remodelling in restrictive anorexia nervosa 35
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 35
Molecular Mechanisms of Cardiovascular Damage Induced by Anti-HER-2 Therapies 34
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors 33
Cardiovascular safety of the tyrosine kinase inhibitor nintedanib 33
Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome 32
Sex-related differences in COVID-19 lethality 32
Effect of Sacubitril-Valsartan in reducing depression in patients with advanced heart failure 32
Novel metrics for risk stratification with nuclear cardiology 31
Sacubitril/valsartan in patients listed for heart transplantation: effect on physical frailty 30
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 29
A nutraceutical combination reduces left ventricular mass in subjects with metabolic syndrome e and left ventricular hypertrophy: A multicenter, randomized, double-blind, placebo-controlled trial 29
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis 29
Efficacy and safety of valsartan plus hydroclorothiazide for high blood pressure 28
A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension 28
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 28
Pharmacovigilating cardiotoxicity of immune checkpoint inhibitors 27
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 27
Prevention of cancer-therapy-related heart failure 27
Prognostic impact of diabetes in chronic and acute heart failure 27
Editorial: Myocardium regeneration and cardioprotection 26
Peripheral Vascular Function in Dilated Cardiomyopathy of Different Etiology 26
Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease? 25
Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurements 25
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments 24
Pulmonary Hypertension Induced by Anticancer Drugs 24
Cardiovascular and metabolic effects of Berberine 24
The broad spectrum of cardiotoxicities from immunotherapies 23
Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors and clinical impact 23
Mechanisms of Cardiovascular Damage Induced by Traditional Chemotherapy 22
Blood lactate in mild and moderate ARDS secondary to SARS COV 2 21
Right ventricular dysfunction in chronic heart failure: clinical laboratory and echocardiographic characteristics. (the RIVED-CHF registry) 18
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 18
Insulin resistance: Is it time for primary prevention? 18
Right heart dysfunction: from pathophysiologic insights to therapeutic options: a translational overview 17
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 16
Innovations in medical therapy of heart failure with reduced ejection fraction 16
Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension 16
Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction 16
Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 16
Non-cardiovascular comorbidities in heart failure patients and their impact on prognosis 16
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond 15
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension 15
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology 15
Response to pulmonary vasodilator treatment in a former smoker with combined interstitial lung disease complicated by pulmonary hypertension: Case report and review of the literature 14
Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances 14
The multifaceted mechanisms of nitroxyl in heart failure: inodilator or ‘only’ vasodilator? 14
Prevention of cardiovascular complications in elderly cancer patients 14
Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: Application of the ESC/ERS risk prediction model 13
Right ventricular longitudinal strain is diminished in systemic sclerosis compared with idiopathic pulmonary arterial hypertension 13
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades 13
Phenotyping pulmonary hypertension in systemic sclerosis: a moving target 12
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome 12
Assessment of right ventricular reserve utilizing exercise provocation in systemic sclerosis 12
Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography 11
Inflammation at the crossroad between cancer and heart failure 11
Causes and outcomes of {ICU} hospitalisations in patients with pulmonary arterial hypertension 10
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 10
Lung ultrasound as diagnostic tool for SARS-CoV-2 infection 10
Essential hypertension worsens left ventricular contractility in systemic sclerosis 10
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 9
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples 9
Echocardiographic assessment and clinical implication of functional tricuspid regurgitation in heart failure with reduced or preserved ejection fraction (ECLIPSE-HF) : Rationale and design of the study 9
Stress Echocardiographic Prediction of Emerging Pulmonary Vascular Disease in Systemic Sclerosis 9
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better 9
Totale 3.565
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.297
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202063 0 0 0 0 0 0 10 5 4 7 20 17
2020/2021220 22 14 6 7 35 7 28 8 13 24 12 44
2021/2022432 4 0 6 14 8 12 24 31 27 29 103 174
2022/20231.018 85 67 58 79 114 88 46 130 190 86 49 26
2023/2024663 44 70 73 52 34 81 33 83 20 27 103 43
2024/2025908 145 186 22 43 61 220 231 0 0 0 0 0
Totale 3.581